For instance, studies show that the risk of colon cancer is less with a low grade of inflammation, which also shows raised CRP; therefore, various anti-inflammatory drugs may act as a novel therapy to reduce the incidence of colon cancer [44,67]. This evidence concerns the gene CRP and colonic neoplasm.